
About Zyg Pharma Private Limited
Data last updated:
Zyg Pharma Private Limited was a private limited company based in Ahmedabad, Gujarat, India. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 August 1987.
The company was registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ1987PTC085170.
The company had an authorised share capital of ₹1.3 Cr and a paid-up capital of ₹16.12 Lakh. It was led by directors including Jinesh Dushyant Shah and Ashok Saligram Modi.
Its last annual general meeting (AGM) was held on 30 June 2015, and its latest financial statements are for the year ended 31 March 2015. The registered office was at Torrent House Off. Ashram Road, Ahmedabad, Gujarat, India – 380009.
The company had about 6 employees on its provident fund (EPFO) records before it was dissolved.
Court records list 5 cases involving the company, including 4 filed by the company and 1 filed against it. The company has 4 deals on record (3 secondary share transfers, 1 acquisition); the latest was in May 2015.
The last known website on record is zygpharma.com.
Company details
CIN history
Zyg Pharma has one previous CIN (Corporate Identification Number): U24230MH1987PTC044312. The current CIN is U24230GJ1987PTC085170, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230GJ1987PTC085170 | Current |
| U24230MH1987PTC044312 | Previous |
Contact details
Zyg Pharma Private Limited's registered office is in Ahmedabad, Gujarat.
- Registered AddressTorrent House Off. Ashram Road, Ahmedabad, Gujarat, India – 380009
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Zyg Pharma Private Limited
FY 2015 filings availableFinancial Statement Summary
| Metrics | FY 2014-15 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2014-15 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Zyg Pharma Private Limited, buy the company report.
Board of directors of Zyg Pharma Private Limited
Zyg Pharma has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jinesh Dushyant Shah Also directs: Zeal Pharma-Chem India Limited, Torrel Cosmetics Limited, Torrel Healthcare Private Limited and 1 more | Additional Director | 17 Jul 2015 | 11 Years 3 Months | As last reported |
| Ashok Saligram Modi | Additional Director | 17 Jul 2015 | 11 Years 3 Months | As last reported |
| Ruchir Dineshchandra Modi Also directs: Pny-Am Designs Private Limited, Puro Wellness Private Limited | Additional Director | 17 Jul 2015 | 11 Years 3 Months | As last reported |
Deals & funding
Zyg Pharma Private Limited has 4 deals on record (3 secondary share transfers, 1 acquisition); the latest was in May 2015.
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| May 2015 | Acquisition | Undisclosed | Buyer: Torrent Pharmaceuticals Ltd |
| Mar 2015 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
| Oct 2014 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
| Mar 2013 | Secondary share transfer | Undisclosed | Buyer: Viren A Merchant HUF, Sudhir A Merchant HUF, 2 individuals Seller: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Zyg Pharma Private Limited has 5 court cases on record: 4 filed by Zyg Pharma, 1 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 5 | 1 | 0 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, GUJARAT | Court case (COMP) | Filed by the company against an individual | Disposed |
| High Court, GUJARAT | Commercial suit | Filed by the company against an individual | Disposed |
| Bombay High Court | Tax appeal | Filed against the company by The Commissioner of Income Tax-7 | Disposed |
| Bombay High Court | Court case (CSD) | Filed by the company | Disposed |
| Bombay High Court | Court case (CSP) | Filed by the company | Disposed |
To see the full case history of Zyg Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Zyg Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Zyg Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Zyg Pharma Private Limited has 7 board changes on record since 2008: 3 appointments and 4 cessations. The latest: Ashok Saligram Modi was appointed as Additional Director on 17 Jul 2015.
Frequently asked questions
Zyg Pharma has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Zyg Pharma was a private limited company based in Ahmedabad, Gujarat, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 17 August 1987 and is registered under CIN U24230GJ1987PTC085170. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Zyg Pharma was incorporated on 17 August 1987. It is registered with the Registrar of Companies, Ahmedabad.
Zyg Pharma had 3 directors:
- Jinesh Dushyant Shah - Additional Director
- Ashok Saligram Modi - Additional Director
- Ruchir Dineshchandra Modi - Additional Director
The CIN (Corporate Identification Number) of Zyg Pharma is U24230GJ1987PTC085170. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Zyg Pharma is at Torrent House Off. Ashram Road, Ahmedabad, Gujarat, India – 380009.
Zyg Pharma can be reached through the website zygpharma.com. Its registered office is in Ahmedabad, Gujarat, India.
The latest financial statements of Zyg Pharma on record with the MCA are for the year ended 31 March 2015. Its last annual general meeting was held on 30 June 2015. Year-wise statements from 2015 are in the company report.
Zyg Pharma operated in the pharma industry, in the drug formulation and development segment.
Zyg Pharma has 4 deals on record (3 secondary share transfers, 1 acquisition); the latest was in May 2015.

